CYP2C9 genetic polymorphisms and warfarin (Q44849911)

6 December 2017

title

CYP2C9 genetic polymorphisms and warfarin (English)

1 reference

6 December 2017

Andrea R Redman

1

1 reference

6 December 2017

Leslie J Dickmann

2

1 reference

6 December 2017

Robert S Kidd

3

1 reference

6 December 2017

Joyce A Goldstein

4

1 reference

6 December 2017

Denise M Ritchie

5

1 reference

6 December 2017

Yuen Yi Hon

6

1 reference

6 December 2017

publication date

1 April 2004

1 reference

Clinical and Applied Thrombosis-Hemostasis

6 December 2017

published in

1 reference

6 December 2017

volume

10

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

149-154

1 reference

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Human P450 metabolism of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Metabolism of warfarin enantiomers in Japanese patients with heart disease having different CYP2C9 and CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

A common genetic basis for idiosyncratic toxicity of warfarin and phenytoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Roles of two allelic variants (Arg144Cys and Ile359Leu) of cytochrome P4502C9 in the oxidation of tolbutamide and warfarin by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Comparative studies on the catalytic roles of cytochrome P450 2C9 and its Cys- and Leu-variants in the oxidation of warfarin, flurbiprofen, and diclofenac by human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Identification of a null allele of CYP2C9 in an African-American exhibiting toxicity to phenytoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000205

10.1177/107602960401000205

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference